Sun Pharmaceutical Industries Ltd. - Research Center
524715 SUNPHARMA Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 20 | Mar' 20 | Dec' 19 | Sep' 19 | Jun' 19 | |
|---|---|---|---|---|---|
| Sales | 3,292.51 | 2,836.08 | 3,013.55 | 3,373.29 | 3,309.01 |
| Operating profit | 787.49 | 228.54 | 705.81 | 834.91 | 942.39 |
| Interest | 13.42 | 137.53 | 98.76 | 114.47 | 57.25 |
| Gross profit | 847.25 | 1,309.66 | 622.41 | 978.77 | 903.72 |
| EPS (Rs) | 3.02 | 4.82 | 1.95 | 3.43 | 3.18 |
Quarterly
results in details
| Sep' 20 | Mar' 20 | Dec' 19 | Sep' 19 | Jun' 19 | |
|---|---|---|---|---|---|
| Other income | 73.18 | 1,218.65 | 15.36 | 258.33 | 18.58 |
| Stock adjustment | -95.47 | 94.28 | -145.17 | 114.58 | 74.91 |
| Raw material | 1,002.72 | 767.12 | 947.21 | 793.57 | 693.81 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 452.16 | 419.34 | 423.97 | 432.77 | 426.69 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,145.61 | 1,326.80 | 1,081.73 | 1,197.46 | 1,171.21 |
| Provisions made | - | - | - | - | - |
| Depreciation | 145.37 | 142.44 | 144.40 | 139.14 | 135.58 |
| Taxation | -22.93 | 11.37 | 9.25 | 16.47 | 4.77 |
| Net profit / loss | 724.81 | 1,155.85 | 468.76 | 823.16 | 763.37 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.92 | 8.06 | 23.42 | 24.75 | 28.48 |
| GPM (%) | 25.17 | 32.30 | 20.55 | 26.95 | 27.16 |
| NPM (%) | 21.54 | 28.51 | 15.48 | 22.67 | 22.94 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis